Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

A double-masked, Placebo-Controlled, Phase 1b/2a Study of EXN407 Eye Drops in Patients with Mild Center Involving Diabetic Macular Edema (DME)

loic Cm lhuillier; Hemal Mehta; Jagjit Gilhotra; Fred Chen; Sanjeewa Wickremasinghe; Wilson Heriot; Peter Davies; Lily Ooi; Jennifer Arnold; Rohan Merani; Mike Taylor; David O Bates; Samantha Fraser-Bell; Mark C Gillies; Mario G Fsadni; Andrew Chang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6248.

ARVO Annual Meeting Abstract June 2023

Six-month Outcomes of Brolucizumab in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry

Mark Gillies; trung dang; Vuong Nguyen; Alessandro Invernizzi; Francesco Romano; Mariano Cozzi; Jennifer Arnold; james wong; hemal mehta; samantha Fraser-Bell; Richard Barry; Daniel Barthelmes; Alan Luckie

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):466.

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289.

ARVO Annual Meeting Abstract June 2020

Multicolour imaging(MCI) in macular telangiectasia type 2A(MacTel) and comparative analysis with fundus autofluorescence(FAF)

Vishal Govindahari; Jay Chhablani; Samantha Fraser-Bell; Apoorva G Ayachit; Alessandro Invernizzi; Unnikrishnan Nair; Sumit Randhir Singh; Marco Lupidi; Dhanya V Nair; Anand Rajendran; Dinah Zur; Roberto Gallego-Pinazo; Rosa Dolz-Marco; Carlo Cagini

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5324.

ARVO Annual Meeting Abstract July 2019

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

Samantha Fraser-Bell; Sophia Zagora; Hemal Mehta; Anna Campain; Hon Seng Wong; Yeung Aaron; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):79.

ARVO Annual Meeting Abstract July 2019

Disorganization of Retinal Inner Layers as a Biomarker in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant

Dinah Zur; Matias Iglicki; Anna Sala-Puigdollers; Jay Chhablani; Marco Lupidi; Samantha Fraser-Bell; Thais Sousa Mendes; Voraporn Chaikitmongkol; Zafer Cebeci; Dolev Dollberg; Catharina Busch; Alessandro Invernizzi; Zohar Habot-Wilner; Anat Loewenstein

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3863.

ARVO Annual Meeting Abstract July 2018

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Elisa Eleanor Cornish; Kelvin Yi Chong Teo; Mark C Gillies; Lyndell L Lim; Ian McAllister; Sutha Sanmugasundram; Vuong Nguyen; Sanjeewa Wickremasinghe; Hemal Mehta; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4847.

ARVO Annual Meeting Abstract July 2018

Dexamethasone Implant for Diabetic Macular Edema in Naïve Compared To Refractory Eyes –A 24 Month The International Retina Group Real-Life Multicenter Study - IRGRel-DEX Study

Catharina Busch; Matias Iglicki; Dinah Zur; Mali Okada; Jay Chhablani; Zafer Cebeci; Samantha Fraser-Bell; Voraporn Chaikitmongkol; Aude Couturier; Ermete Giancipoli; Patricio Rodriguez; Matus Rehak; Marco Lupidi; Adrian Tien-Chin Fung; Michaella Goldstein; Anat Loewenstein

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1956.

ARVO Annual Meeting Abstract June 2017

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years – Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

Hemal Mehta; Samantha Fraser-Bell; Vuong Nguyen; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1895.

Clinical and Epidemiologic Research October 2016

Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema

PDF

Christine Aroney; Samantha Fraser-Bell; Ecosse L. Lamoureux; Mark C. Gillies; Lyndell L. Lim; Eva K. Fenwick
TAGS: bevacizumab, dexamethasone, diabetic macular edema, implants, intravitreal implants, quality of life, vision, questionnaires, visual impairment
Invest. Ophthalmol. Vis. Sci.. 2016; 57(13):5541-5546. https://doi.org/10.1167/iovs.16-19729

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema

Lyndell L Lim; Dania Qatarneh; Lauren Hodgson; Hemal Mehta; Sanjeewa Wickremasinghe; Anna Campain; Mark C Gillies; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2106.

ARVO Annual Meeting Abstract June 2015

BEVORDEX - A multicentre randomized clinical trial of intravitreal dexamethasone versus intravitreal bevacizumab for persistent diabetic macular edema

Mark C Gillies; Lyndell L Lim; Anna E Campain; Hemal Mehta; Godfrey Quin; Samantha Fraser-Bell; Ian McAllister; Wedad Salem; Ji Li

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3144.

ARVO Annual Meeting Abstract April 2014

BEVORDEX - A multicentre randomized clinical trial of intravitreal bevacizumb versus intravitreal dexamethasone for persistent diabetic macular oedema.

Mark C Gillies; Lyndell L Lim; Anna Campain; Goff Quin; Wedad Salem; Ji Li; Stephanie Goodwin; Christine Aroney; Ian McAllister; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5053.

ARVO Annual Meeting Abstract June 2013

A retrospective analysis of the natural history and management of serpiginous choroidopathy (SC) in Australia and New Zealand

Anthony Hall; Jason Toniolo; Jo Sims; Samantha Fraser-Bell; Jane Khan; Christine Younan; Brian Kent-Smith; Stephanie Young; Eldho Paul; Lyndell Lim; Australian and New Zealand Ophthalmic Surveillance Unit (ANZOSU)

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5385.

Immunology and Microbiology May 2011

Punctate Inner Choroidopathy and Multifocal Choroiditis with Panuveitis Share Haplotypic Associations with IL10 and TNF Loci

PDF

Denize Atan; Samantha Fraser-Bell; Jarka Plskova; Lucia Kuffová; Aideen Hogan; Adnan Tufail; Dara J. Kilmartin; John V. Forrester; Jeff L. Bidwell; Andrew D. Dick; Amanda J. Churchill
TAGS: choroid diseases, choroiditis, interleukin-10, panuveitis, syndrome, tumor necrosis factors, disease susceptibility
Invest. Ophthalmol. Vis. Sci.. 2011; 52(6):3573-3581. https://doi.org/10.1167/iovs.10-6743

ARVO Annual Meeting Abstract April 2011

Exploring Parameters That May Be Associated With The Efficacy Of Response To Intravitreal Bevacizumab (ivB) In A Two-year Prospective Randomised Trial Comparing ivB With Laser Therapy In The Management Of Diabetic Macular Oedema (BOLT Study)

Michel Michaelides; Simona Esposti; Ranjan Rajendram; Robin Hamilton; Andrew Kaines; Samantha Fraser-Bell; Cathy Egan; Tunde Peto; Catey Bunce; Phil Hykin

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5334.

Immunology and Microbiology August 2010

Cytokine Polymorphism in Noninfectious Uveitis

PDF

Denize Atan; Samantha Fraser-Bell; Jarka Plskova; Lucia Kuffova; Aideen Hogan; Adnan Tufail; Dara J. Kilmartin; John V. Forrester; Jeff Bidwell; Andrew D. Dick; Amanda J. Churchill
TAGS: cytokine, interleukin-10, polymorphism, uveitis, tumor necrosis factors, single nucleotide polymorphism
Invest. Ophthalmol. Vis. Sci.. 2010; 51(8):4133-4142. https://doi.org/10.1167/iovs.09-4583

Includes: Supplemental Content

Clinical and Epidemiologic Research December 2005

Refractive Error, Ocular Biometry, and Lens Opalescence in an Adult Population: The Los Angeles Latino Eye Study

PDF

Chrisandra Shufelt; Samantha Fraser-Bell; Mei Ying-Lai; Mina Torres; Rohit Varma
TAGS: biometry, eye, hispanics or latinos, lens (device), lens, crystalline, refractive errors, adult, cornea, gender, vitreous body
Invest. Ophthalmol. Vis. Sci.. 2005; 46(12):4450-4460. https://doi.org/10.1167/iovs.05-0435

Clinical and Epidemiologic Research June 2004

Prevalence and Associations of Epiretinal Membranes in Latinos: The Los Angeles Latino Eye Study

PDF

Samantha Fraser-Bell; Mei Ying-Lai; Ronald Klein; Rohit Varma
TAGS: cardiac mri, epiretinal membrane, eye, hispanics or latinos, prevalence, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2004; 45(6):1732-1736. https://doi.org/10.1167/iovs.03-1295

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A double-masked, Placebo-Controlled, Phase 1b/2a Study of EXN407 Eye Drops in Patients with Mild Center Involving Diabetic Macular Edema (DME)

Six-month Outcomes of Brolucizumab in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

Multicolour imaging(MCI) in macular telangiectasia type 2A(MacTel) and comparative analysis with fundus autofluorescence(FAF)

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

Disorganization of Retinal Inner Layers as a Biomarker in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Dexamethasone Implant for Diabetic Macular Edema in Naïve Compared To Refractory Eyes –A 24 Month The International Retina Group Real-Life Multicenter Study - IRGRel-DEX Study

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years – Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema

Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema

BEVORDEX - A multicentre randomized clinical trial of intravitreal dexamethasone versus intravitreal bevacizumab for persistent diabetic macular edema

BEVORDEX - A multicentre randomized clinical trial of intravitreal bevacizumb versus intravitreal dexamethasone for persistent diabetic macular oedema.

A retrospective analysis of the natural history and management of serpiginous choroidopathy (SC) in Australia and New Zealand

Punctate Inner Choroidopathy and Multifocal Choroiditis with Panuveitis Share Haplotypic Associations with IL10 and TNF Loci

Exploring Parameters That May Be Associated With The Efficacy Of Response To Intravitreal Bevacizumab (ivB) In A Two-year Prospective Randomised Trial Comparing ivB With Laser Therapy In The Management Of Diabetic Macular Oedema (BOLT Study)

Cytokine Polymorphism in Noninfectious Uveitis

Refractive Error, Ocular Biometry, and Lens Opalescence in an Adult Population: The Los Angeles Latino Eye Study

Prevalence and Associations of Epiretinal Membranes in Latinos: The Los Angeles Latino Eye Study

To View More...

You must be signed into an individual account to use this feature.